Cargando…

Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function

The human gut relies on several cellular and molecular mechanisms to allow for an intact and dynamical intestinal barrier. Normally, only small amounts of luminal content pass the mucosa, however, if the control is broken it can lead to enhanced passage, which might damage the mucosa, leading to pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoultz, Ida, Keita, Åsa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407030/ https://www.ncbi.nlm.nih.gov/pubmed/30813280 http://dx.doi.org/10.3390/cells8020193

Ejemplares similares

The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
por: Schoultz, Ida, et al.
Publicado: (2020)

Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome
por: Martínez, Cristina, et al.
Publicado: (2012)

Potential neuro-immune therapeutic targets in irritable bowel syndrome
por: Casado-Bedmar, Maite, et al.
Publicado: (2020)

Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition
por: Keita, Åsa V, et al.
Publicado: (2018)

NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease
por: Zhou, Feng, et al.
Publicado: (2023)

Procoagulatory State in Inflammatory Bowel Diseases Is Promoted by Impaired Intestinal Barrier Function
por: Pastorelli, Luca, et al.
Publicado: (2015)

Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress?
por: Ganda Mall, John-Peter, et al.
Publicado: (2018)

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
por: Mishra, Jayshree, et al.
Publicado: (2022)

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2021)

Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis
por: Samoilă, Iuliana, et al.
Publicado: (2020)

Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases
por: Mazur, Marzena, et al.
Publicado: (2021)

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
por: Sun, Jing, et al.
Publicado: (2016)

Molecular Basis of Intestinal Fibrosis in Inflammatory Bowel Disease
por: Andoh, Akira, et al.
Publicado: (2022)

Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets
por: Weidinger, Carl, et al.
Publicado: (2021)

Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial
por: Ganda Mall, John-Peter, et al.
Publicado: (2020)

The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms
por: Caruso, Giuseppe, et al.
Publicado: (2023)

Intestinal Stem Cells and Immune Cell Relationships: Potential Therapeutic Targets for Inflammatory Bowel Diseases
por: Hou, Qihang, et al.
Publicado: (2021)

Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis
por: Rapa, Shara Francesca, et al.
Publicado: (2021)

miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease
por: Xiao, Xiangjun, et al.
Publicado: (2022)

Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier
por: Tian, Yonggang, et al.
Publicado: (2022)

Intestinal barrier in inflammatory bowel disease: A bibliometric and knowledge-map analysis
por: Zhou, Feng, et al.
Publicado: (2023)

Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome
por: Büttner, Janine, et al.
Publicado: (2023)

Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease
por: Cheng, Yang, et al.
Publicado: (2021)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
por: Lee, Jessica Y., et al.
Publicado: (2018)

Increasing the qualitative understanding of optimal functionality in older adults: a focus group based study
por: Algilani, Samal, et al.
Publicado: (2016)

Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden
por: Shrestha, Sarita, et al.
Publicado: (2022)

Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms
por: Ganda Mall, J. P., et al.
Publicado: (2018)

New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease
por: Liang, Bing, et al.
Publicado: (2022)

Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
por: Yue, Bei, et al.
Publicado: (2020)

Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease
por: Hu, Xinyu, et al.
Publicado: (2022)

Resveratrol in Intestinal Health and Disease: Focusing on Intestinal Barrier
por: Wang, Youxia, et al.
Publicado: (2022)

Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease
por: Chen, Yongyan, et al.
Publicado: (2021)

Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease
por: Iyer, Namrata, et al.
Publicado: (2021)

Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota
por: Huang, Pan, et al.
Publicado: (2022)

The Importance of Nutritional Aspects in the Assessment of Inflammation and Intestinal Barrier in Patients with Inflammatory Bowel Disease
por: Kaczmarczyk, Olga, et al.
Publicado: (2022)

Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapy
por: Zhao, Yuge, et al.
Publicado: (2023)

Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets
por: Nanini, Hayandra Ferreira, et al.
Publicado: (2018)

Identification of Novel Therapeutic Molecular Targets in Inflammatory Bowel Disease by Using Genetic Databases
por: Mohan, Sachin, et al.
Publicado: (2020)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease
por: Mao, Qijiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hcrm2mkt04qi44kps864egbbrs